Skip to main content
SpringerLink
Log in

The Protective Effect of Chrysin Against Cisplatin İnduced Ototoxicity in Rats

  • Original Article
  • Published:
Indian Journal of Otolaryngology and Head & Neck Surgery Aims and scope Submit manuscript

Abstract

Ototoxicity is a common side effect of cisplatin chemotherapy. The aim of this study was to investigate the potential protective effect of chrysin against cisplatin-induced ototoxicity. Thirty-four adult female Wistar albino rats were separated into four groups: a cisplatin group (Group A), with cisplatin administered to ten rats once daily for three consecutive days at doses of 8 mg/kg body weight intraperitoneally (i.p.); a cisplatin plus chrysin group (Group B), with 8 mg/kg of cisplatin administered i.p. daily to ten rats for three consecutive days and 25 mg/kg of chrysin administered via oral gavage in a corn oil for 5 days: a chrysin group (Group C), with 25 mg/kg of chrysin administered via oral gavage in corn oil for 5 days to seven rats; and a control group (Group D), with 5 ml/kg of corn oil administered to seven rats via oral gavage for 5 days. Distortion product otoacoustic emission measurements were performed in the same ear of the rats under general anesthesia at baseline and on the first and fifth days after drug administration. No significant differences were noted between the measurements either in the chrysin group or in the control group. In the cisplatin group, there was a significant worsening of hearing compared to baseline and the measurements on the fifth day at all frequencies. In the statistical analysis, a statistically significant difference was observed at 5039, 6351, 8003, and 10078 Hz frequencies between the measurements on the first and fifth days. In the cisplatin plus chrysin group, there were statistically significant differences at frequencies of 2,003 and 5,039 Hz between the measurements at baseline and on the fifth day, at 3,175 and 5,039 Hz between the measurements on the first and fifth days, and at 8,003 and 100,078 Hz between the measurements at baseline and on the first day. According to these results, this study demonstrates that cisplatin-related ototoxicity can be prevented in rats by the administration of chrysin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Rybak LP, Mukherjea D, Jajoo S, Ramkumar V (2009) Cisplatin ototoxicity and protection: clinical and experimental studies. Tohoku J Exp Med 219(3):177–186

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  2. Rybak LP, Ramkumar V (2007) Ototoxicity. Kidney Int 72(8):931–935

    Article  PubMed  CAS  Google Scholar 

  3. Clerici WJ, Hensley K, DiMartino DL, Butterfield DA (1996) Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hear Res 98(1–2):116–124

    Article  PubMed  CAS  Google Scholar 

  4. Yumusakhuylu AC, Yazici M, Sari M, Binnetoglu A, Kosemihal E, Akdas F, Sirvanci S, Yuksel M, Uneri C, Tutkun A (2012) Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs. Int J Pediatr Otorhinolaryngol 76(3):404–408

    Article  PubMed  Google Scholar 

  5. Kizilay A, Kalcioglu MT, Ozerol E, Iraz M, Gulec M, Akyol O, Ozturan O (2004) Caffeic acid phenethyl ester ameliorated ototoxicity induced by cisplatin inrats. J Chemother 16(4):381–387

    Article  PubMed  CAS  Google Scholar 

  6. Korver KD, Rybak LP, Whitworth C, Campbell KM (2002) Round window application of d-methionine provides complete cisplatin otoprotection. Otolaryngol Head Neck Surg 126(6):683–689

    Article  PubMed  Google Scholar 

  7. Daldal A, Odabasi O, Serbetcioglu B (2007) The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs. Otolaryngol Head Neck Surg 137(5):747–752

    Article  PubMed  Google Scholar 

  8. Chen X, Frisina RD, Bowers WJ, Frisina DR, Federoff HJ (2001) HSV amplicon-mediated neurotrophin-3 expression protects murine spiral ganglion neurons from cisplatin-induced damage. Mol Ther 3(6):958–963

    Article  PubMed  CAS  Google Scholar 

  9. So HS, Park C, Kim HJ, Lee JH, Park SY, Lee JH, Lee ZW, Kim HM, Kalinec F, Lim DJ, Park R (2005) Protective effect of T-type calcium channel blocker flunarizine on cisplatin-induced death of auditory cells. Hear Res 204(1–2):127–139

    Article  PubMed  CAS  Google Scholar 

  10. Church MW, Blakley BW, Burgio DL, Gupta AK (2004) WR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: dose-dependent effects. J Assoc Res Otolaryngol 5(3):227–237

    Article  PubMed  PubMed Central  Google Scholar 

  11. Choe WT, Chinosornvatana N, Chang KW (2004) Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate. Otol Neurotol 25(6):910–915

    Article  PubMed  Google Scholar 

  12. Yoo J, Hamilton SJ, Angel D, Fung K, Franklin J, Parnes LS, Lewis D, Venkatesan V, Winquist E (2013) Cisplatin otoprotection using transtympanic l-N-acetylcysteine: a pilot randomized study in head and neck cancer patients. Laryngoscope. doi:10.1002/lary.24360

    Google Scholar 

  13. Kalcioglu MT, Kizilay A, Gulec M, Karatas E, Iraz M, Akyol O, Egri M, Ozturan O (2005) The protective effect of erdosteine against ototoxicity induced by cisplatin in rats. Eur Arch Otorhinolaryngol 262(10):856–863

    Article  PubMed  Google Scholar 

  14. Hyppolito MA, de Oliveira JA, Rossato M (2006) Cisplatin ototoxicity and otoprotection with sodium salicylate. Eur Arch Otorhinolaryngol 263(9):798–803

    Article  PubMed  Google Scholar 

  15. Huang X, Whitworth CA, Rybak LP (2007) Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats. Otol Neurotol 28(6):828–833

    Article  PubMed  Google Scholar 

  16. Lynch ED, Gu R, Pierce C, Kil J (2005) Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen. Hear Res 201(1–2):81–89

    Article  PubMed  CAS  Google Scholar 

  17. Erdem T, Bayindir T, Filiz A, Iraz M, Selimoglu E (2012) The effect of resveratrol on the prevention of cisplatin ototoxicity. Eur Arch Otorhinolaryngol 269(10):2185–2188

    Article  PubMed  CAS  Google Scholar 

  18. Sagit M, Korkmaz F, Akcadag A, Somdas MA (2013) Protective effect of thymoquinone against cisplatin-induced ototoxicity. Eur Arch Otorhinolaryngol 270(8):2231–2237

    Article  PubMed  Google Scholar 

  19. Bayindir T, Iraz M, Kelles M, Kaya S, Tan M, Filiz A, Toplu Y, Kalcioglu MT (2013) The effect of betaglucan on cisplatin ototoxicity. Indian J Otolaryngol Head Neck Surg. doi:10.1007/s12070-013-0623-0

    PubMed Central  Google Scholar 

  20. Cicek MT, Kalcioglu MT, Bayindir T, Toplu Y, Iraz M (2013) The effect of lycopene on the ototoxicity induced by cisplatin. Turk J Med Sci. doi:10.3906/sag-1304-66

    Google Scholar 

  21. Rapta P, Misík V, Stasko A, Vrábel I (1995) Redox intermediates of flavonoids and caffeic acid esters from propolis: an EPR spectroscopy and cyclic voltammetry study. Free Radic Biol Med. 18(5):901–908

    Article  PubMed  CAS  Google Scholar 

  22. Williams CA, Harborne JB, Newman M, Greenham J, Eagles J (1997) Chrysin and other leaf exudate flavonoids in the genus Pelargonium. Phytochemistry 46(8):1349–1353

    Article  PubMed  CAS  Google Scholar 

  23. Hecker M, Preiss C, Klemm P, Busse R (1996) Inhibition by antioxidants of nitric oxide synthase expression in murine macrophages: role of nuclear factor kappa B and interferon regulatory factor 1. Br J Pharmacol 118(8):2178–2184

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  24. Cho H, Yun CW, Park WK, Kong JY, Kim KS, Park Y, Lee S, Kim BK (2004) Modulation of the activity of pro-inflammatory enzymes, COX-2 and iNOS, by chrysin derivatives. Pharmacol Res 49(1):37–43

    Article  PubMed  CAS  Google Scholar 

  25. Pearce FL, Befus AD, Bienenstock J (1984) Mucosal mast cells. III. Effect of quercetin and other flavonoids on antigen-induced histamine secretion from rat intestinal mast cells. J Allergy Clin Immunol 73(6):819–823

    Article  PubMed  CAS  Google Scholar 

  26. Cárdenas M, Marder M, Blank VC, Roguin LP (2006) Antitumor activity of some natural flavonoids and synthetic derivatives on various human and murine cancer cell lines. Bioorg Med Chem 14(9):2966–2971

    Article  PubMed  Google Scholar 

  27. Wolfman C, Viola H, Paladini A, Dajas F, Medina JH (1994) Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea. Pharmacol Biochem Behav 47(1):1–4

    Article  PubMed  CAS  Google Scholar 

  28. Kao YC, Zhou C, Sherman M, Laughton CA, Chen S (1998) Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: a site-directed mutagenesis study. Environ Health Perspect 106(2):85–92

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  29. Tsukasaki N, Whitworth CA, Rybak LP (2000) Acute changes in cochlear potentials due to cisplatin. Hear Res 149(1–2):189–198

    Article  PubMed  CAS  Google Scholar 

  30. van Ruijven MW, de Groot JC, Klis SF, Smoorenburg GF (2005) The cochlear targets of cisplatin: an electrophysiological and morphological time-sequence study. Hear Res 205(1–2):241–248

    Article  PubMed  Google Scholar 

  31. Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V (2007) Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res 226(1–2):157–167

    Article  PubMed  CAS  Google Scholar 

  32. Dehne N, Lautermann J, Petrat F, Rauen U, de Groot H (2001) Cisplatin ototoxicity:involvement of iron and enhanced formation of superoxide anion radicals. Toxicol Appl Pharmacol 174(1):27–34

    Article  PubMed  CAS  Google Scholar 

  33. Waissbluth S, Salehi P, He X, Daniel SJ (2013) Systemic dexamethasone for the prevention of cisplatin-induced ototoxicity. Eur Arch Otorhinolaryngol 270(5):1597–1605

    Article  PubMed  Google Scholar 

  34. Hyppolito MA, de Oliveira JA, Rossato M (2006) Cisplatin ototoxicity and otoprotection with sodium salicylate. Eur Arch Otorhinolaryngol 263(9):798–803

    Article  PubMed  Google Scholar 

  35. Riga MG, Chelis L, Kakolyris S, Papadopoulos S, Stathakidou S, Chamalidou E, Xenidis N, Amarantidis K, Dimopoulos P, Danielides V (2013) Transtympanic injections of N-acetylcysteine for the prevention of cisplatin-induced ototoxicity: a feasible method with promising efficacy. Am J Clin Oncol 36(1):1–6

    Article  PubMed  CAS  Google Scholar 

  36. Duval M, Daniel SJ (2012) Meta-analysis of the efficacy of amifostine in the prevention of cisplatin ototoxicity. J Otolaryngol Head Neck Surg. 41(5):309–315

    PubMed  Google Scholar 

  37. Li X, Huang Q, Ong CN, Yang XF, Shen HM (2010) Chrysin sensitizes tumor necrosis factor-alpha-induced apoptosis in human tumor cells via suppression of nuclear factor-kappaB. Cancer Lett 293(1):109–116

    Article  PubMed  CAS  Google Scholar 

  38. Sultana S, Verma K, Khan R (2012) Nephroprotective efficacy of chrysin against cisplatin-induced toxicity via attenuation of oxidative stress. J Pharm Pharmacol 64(6):872–881

    Article  PubMed  CAS  Google Scholar 

  39. Khan R, Khan AQ, Qamar W, Lateef A, Tahir M, Rehman MU, Ali F, Sultana S (2012) Chrysin protects against cisplatin-induced colon. toxicity via amelioration of oxidative stress and apoptosis: probable role of p38MAPK and p53. Toxicol Appl Pharmacol 258(3):315–329

    Article  PubMed  CAS  Google Scholar 

  40. Khan R, Khan AQ, Qamar W, Lateef A, Ali F, Rehman MU, Tahir M, Sharma S, Sultana S (2012) Chrysin abrogates cisplatin-induced oxidative stress, p53 expression, goblet cell disintegration and apoptotic responses in the jejunum of Wistar rats. Br J Nutr 108(9):1574–1585

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Otorhinolaryngology, Sutcu Imam University, Kahramanmaras, Turkey

    Mehmet Kelles

  2. Department of Otorhinolaryngology, Inonu University, Malatya, Turkey

    Mehmet Tan & Yuksel Toplu

  3. Department of Otorhinolarngology, Istanbul Medeniyet University Medical Faculty, Istanbul, Turkey

    M. Tayyar Kalcioglu

  4. Turgut Ozal Medical Center, Inonu University, Malatya, Turkey

    Nazire Bulam

Authors
  1. Mehmet Kelles
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mehmet Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Tayyar Kalcioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuksel Toplu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nazire Bulam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Tayyar Kalcioglu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kelles, M., Tan, M., Kalcioglu, M.T. et al. The Protective Effect of Chrysin Against Cisplatin İnduced Ototoxicity in Rats. Indian J Otolaryngol Head Neck Surg 66, 369–374 (2014). https://doi.org/10.1007/s12070-013-0695-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12070-013-0695-x

Keywords

Search

Navigation